LEUVEN, BELGIUM – Euro NCAP’s independent assessment of the new CLA shows an outstanding safety performance with a five-star result…
ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients Glasmacinal, a novel macrolide, was well…
December 05, 2025 08:00 ET | Source: UroGen Pharma Ltd. PRINCETON, N.J., Dec. 05, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma…
MUMBAI, India, Nov. 28, 2025 /PRNewswire/ -- Positioned as a rapidly developing residential town along the Mumbai-Pune corridor, Khopoli is…
Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its October 27th Registered Direct Offering November 24, 2025…
November 21, 2025 16:06 ET | Source: Supernus Pharmaceuticals, Inc. ROCKVILLE, Md., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals,…
BEIJING, Nov. 23, 2025 /PRNewswire/ -- CGTN published an article on the G20 summit's first landing in Africa, highlighting China's…
HANOI, Vietnam, Nov. 11, 2025 /PRNewswire/ -- On November 10, within the framework of the Defense & Security Exhibition 2025…
POMPANO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Curonix LLC (“Curonix” or the “Company”), a medical technology company dedicated…
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…